Basic Information
Magenta Therapeutics is a biotechnology company that brings revolutionary bone marrow transplants to patients with autoimmune diseases, blood cancers, and genetic disorders. By creating a platform focused on critical areas of unmet need, Magenta has pioneered an integrated approach that conducts research in four key aspects: pre-transplant patient preparation, stem cell collection, stem cell expansion, and post-transplant complications. By making the process more efficient, safe, and accessible, Magenta extends the curative potential of bone marrow transplants to more patients.
Magenta Therapeutics,Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2016
--

